Endpoints News Mar 3, 2026 Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
Endpoints News Feb 25, 2026 Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy
Endpoints News Feb 21, 2026 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Endpoints News Feb 11, 2026 Prasad overruled vaccine review team, office director on Moderna flu shot
Endpoints News Feb 10, 2026 Moderna accuses FDA of shifting standard as agency refuses flu shot review
Endpoints News Nov 21, 2025 Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna #Blue Lake #Inhibikase Therapeutics